It supports your body's internal systems rather than just providing an external source
In fact, recent clinical trials have shown that people with type 2 diabetes who have taken a dual agonist had the following markers improve significantly: body weight fasting and after-eating glucose levels insulin sensitivity total cholesterol The only GLP-1/GIP dual agonist currently on the market is tirzepatide, branded under Mounjaro
Introduction GLP1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) suppress appetite by an average of 30 to 50 percent, but that number hides enormous individual variation
BPC-157 peptide is not FDA-approved for any indication in the United States
The HMR Program utilizes behavioral change strategies, such as goal setting and tracking, paired with health coaching around nutrition and physical activity, to address many pillars of health, including sustainable weight loss, whereas GLP-1RA medication alone may only address changes in body weight while using the medication
Peptides like hCG and kisspeptin-10 more directly stimulate testosterone production through the HPG axis